{"url":"https://lda.senate.gov/api/v1/filings/d85711df-e6dc-4658-8079-64abf4e1d571/","filing_uuid":"d85711df-e6dc-4658-8079-64abf4e1d571","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2014,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d85711df-e6dc-4658-8079-64abf4e1d571/print/","filing_document_content_type":"text/html","income":null,"expenses":"20000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Elizabeth Terry","dt_posted":"2015-01-18T13:12:34.250000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1301 K St., NW","registrant_address_2":"Suite 1100 East Tower","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":321112,"url":"https://lda.senate.gov/api/v1/registrants/321112/","house_registrant_id":39609,"name":"OMNICARE, INC.","description":null,"address_1":"1301 K St., NW","address_2":"Suite 1100 East Tower","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH TERRY","contact_telephone":"+1 202-772-3526","dt_updated":"2022-04-06T16:07:55.597396-04:00"},"client":{"id":186752,"url":"https://lda.senate.gov/api/v1/clients/186752/","client_id":12,"name":"OMNICARE INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1899-12-30"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Drug Enforcement Administration rule on disposal of controlled substances in long term care facilities;\nReclassification of hydrocodone-containing prescription drugs from Schedule III to Schedule II drugs;\nControlled substances policy;\nBiosimilars policy;\nHazardous drug handling policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58925,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"TERRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Part D reimbursement;\nMedicare Part D audit policy;\nMedicare anti-fraud, waste and abuse policy;\nMedicaid FFS drug reimbursement;\nMedicare innovative health care and delivery models;\nPost-acute care payment policy reform;\nMedicare Part D network access issues;\nSafe-harbor and anti-kickback policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58925,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"TERRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}